Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
Prodromal Symptoms of Multiple Sclerosis in Primary Care
Ann Neurol 83:1162-1173, Disanto,G.,et al, 2018
Dentate Update: Imaging Features of Entities that Affect the Dentate Nucleus
AJNR 38:1467-1474, Bond, K.M.,et al, 2017
Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014
Cortical Pathology in Multiple Sclerosis Patients with Epilepsy: A 3 Year Longitudinal Study
JNNP 83:49-54, Calabrese, M.,et al, 2012
Rhombencephalitis A Series of 97 Patients
Medicine 90:256-261, Moragas, M.,et al, 2011
Clinicopath Conf, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NEJM 360:1656-1665, Case 12-2009, 2009
Memantine Induces Reversible Neurologic Impairment in Patients with MS
Neurol 72:1630-1633, Villoslada,P.,et al, 2009
Multiple Sclerosis with Predominant, Severe Cognitive Impairment
Arch Neurol 66:1139-1143, Staff,N.,et al, 2009
Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008
Multiple Sclerosis and Cannabis: A Cognitive and Psychiatric Study
Neurol 71:164-169, Ghaffar,O. &Feinstein,A., 2008
Thalamic Atrophy and Cognition in Multiple Sclerosis
Neurol 69:1213-1223, Houtchens,M.K.,et al, 2007
Gray and White Matter Brain Atrophy and Neuropsychological Impairment in Multiple Sclerosis
Neurol 66:685-692, Sanfilipo,M.P.,et al, 2006
Migraine and Cerebral White Matter Lesions
The Neurologist 11:19-29, Gladstone,J.P. &Dodick,D.W., 2005
Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003
The Influence of Cognitive Impairment on Driving Performance in Multiple Sclerosis
Neurol 56:1089-1094, Schultheis,M.R.,et al, 2001
Comparisons of Patient Self-report, Neurologic Examination, and Functional Impairment in MS
Neurol 56:934-937, Hoogervorst,E.L.J.,et al, 2001
De Novo Mutation in the Notch3 Gene Causing CADASIL
Ann Neurol 47:388-391, Joutel,A.,et al, 2000
Neuropsychological Status in Multiple Sclerosis after Treatment with Glatiramer
Arch Neurol 56:319-324, Weinstein,A.,et al, 1999
Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999
Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
The Phenotypic Spectrum of CADASIL:Clinical Findings in 102 Cases,
Ann Neurol 44:731-739,715, Dichgans,M.,et al, 1998
Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997
Unusual Causes of Headache
Neurol 48:1494-1499, Ramadan,N.M., 1997
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Dementia in 2 Histologically Confirmed Cases of MS:One Isolated Dementia & One Assoc with Psychiatric Symptoms
JNNP 57:353-359, Fontaine,B.,et al, 1994
Information Processing Efficiency in Chronic Fatigue Syndromes and Multiple Sclerosis
Arch Neurol 50:301-304, DeLuca,J.,et al, 1993
Multiple Sclerosis Dementia
Neurol 42:696, Mendez,M.D.&Frey,W.F., 1992
Event-Related Potential P300 in MS, Relation to Magnetic Resonance Imaging and Cognitive Impairment
Arch Neurol 49:44-50, Honig,L.S.,et al, 1992
Fecal Incontinence
NEJM 326:1002-1007, Madoff,R.D.,et al, 1992
Cognitive Dysfunction in MS, II. Impact on Employment and Social Functioning
Neurol 41:692-696, Rao,S.M.,et al, 1991
Cognitive Loss in Multiple Sclerosis
Arch Neurol 46:162-167, Franklin,G.M.,et al, 1989
Correlation of Magnetic Resonance Imaging with Neuropsychological Testing in Multiple Sclerosis
Neurol 39:161-166, Rao,S.M.,et al, 1989
Magnetic Resonance Imaging of the Central Nervous System Council on Scientific Affairs
Report of the Panel on MRI, JAMA 259:1211-12221988., , 1988
Correlation of Neuropsychological and MRI Findings in Chronic/Progressive Multiple Sclerosis
Neurol 38:1826-1829, Franklin,G.M.,et al, 1988
Cerebral Magnetic Resonance Imaging Findings in MS, Relation to Affect, Drive and Cognition
Arch Neurol 45:1114-1116, Reischies,F.M.,et al, 1988
Magnetic Resonance Imaging Correlates of Dementia in Multiple Sclerosis
Arch Neurol 44:732-736, Huber,S.J.,et al, 1987
Disease Activity & Emotional State in Multiple Sclerosis
Ann Neurol 13:573-577, Dalos,N.P.,et al, 1983
Psychological Profiles in Patients With Multiple Sclerosis, A Preliminary Investigation
Arch Neurol 37:437-440, Peyser,J.M.,et al, 1980
Multiple Sclerosis & Hysteria, Lessons Learned From Their Association
JAMA 243:2418-2421, Caplan,L.R.,et al, 1980
Cognitive Function in Patients With Multiple Sclerosis
Arch Neurol 37:577-579, Peyser,J.M.,et al, 1980
Multiple Sclerosis Presenting with Acute Remitting Psychiatric Symptoms
JNNP 42:859-863, Matthews,W.B., 1979
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Organic Disease Presenting as a Psychiatric Syndrome
Postgrad Med 54:78, , 1973
Narcolepsy
NEJM 288:1156, Zarcone,V., 1973
Myelinoclastic Diffuse & Transitional Sclerosis
Handbook of Clinical Neurol, Ed by Vinken & Bruyn 9:46970., Poser,C., 1970